Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG) – Recap
Despite only providing a fleeting opportunity for gains on Tuesday morning after we submitted our options trading idea for the JNUG chain, we followed up with a reminder in yesterday’s report that the idea was still in play, and that we’d need to keep our heads on a swivel looking out for the move we were hoping for.
With the help of a Fed rate hike of a quarter of a percentage point, announced by Chairperson Janet Yellen yesterday, our specified contracts, the JNUG 03/31 $7-8 Calls took a serious turn for the better.
The daily ranges and potential profits were as follows:
$7 Calls – Range: .40-1.40 – Max Gain: 250%
$7.50 Calls – Range: .35-1.00 – Max Gain: 186%
$8 Calls – Range: .20-.87 – Max Gain: 335%
Once again, we’re going to reiterate our interest in these ideas, which could be in line to extend their highs, with JNUG gapping up in early trading this morning.
Aralez Pharmaceuticals, Inc. ARLZ
We placed ARLZ on bottom watch yesterday morning in what turned out to be a fantastic stroke of good timing. We just wanted to update readers this morning on the reversal which did indeed occur during the session. While the intraday gain potential topped out at 25% as the stock ran from the open (and also low of day) at 2.11 to as much as 2.63.
The inverted hammer candle that the stock posted yesterday is often thought to be an indicator of the end of a downward pattern, so we’ll be very interested to continue tracking ARLZ in sessions to come. Chart indicators are still looking very ripe, and we’d be surprised if the show was over after just a 25% rise.
Cannabis Sector Comments
Lastly, we just want to address the cannabis sector, particularly those stocks that are connected to legal recreational marijuana. After some very damaging comments made recently by the Trump Administration wherein it was suggested that the government could crack down on legal weed, yesterday we witnessed something of a reversal from Jeff Sessions.
Sessions appeared to hint at insufficient DOJ funding as a primary reason that perhaps the current regime will not be changing Obama-era guidance on leaving the treatment of recreational weed as a states’ rights issue.
On the heels of this development, we’re going to want to keep closer tabs on the cannabis sector once again, particularly those plays that lost a lot of ground after the first round of comments from Washington.
Some of our go-to favorites in the space have been OWCP, TRTC, SING, SGDH, CBIS, and MJNA, so we’ll be tracking these more closely in the days and weeks ahead, along with the sector as a whole, as stated above.
Fresh Options Idea:
The TSLA chart is looking ripe for a recovery, and the stock is gapping up moderately in premarket trading this morning. We want to signal a range of calls to monitor in the TSLA chain to potentially take advantage of what could be a protracted recovery. We’re going to zero in on the TSLA 04/07 $270-277.50 Calls, and monitor them in the days and weeks ahead.
NAK, ZSAN, ORCL, TPLM, PLX, RXII, IDRA
Incoming search terms:
- is mjna a good idea